InvestorsHub Logo
Followers 14
Posts 2847
Boards Moderated 0
Alias Born 12/23/2014

Re: None

Tuesday, 01/26/2021 9:20:23 AM

Tuesday, January 26, 2021 9:20:23 AM

Post# of 459
2/26 Two downgrades
Canaccord Genuity analyst Kyle Rose downgrades Repro-Med Systems (NASDAQ:KRMD) from Buy to Hold and announces $5 price target.

Piper Sandler analyst Matthew O'Brien downgrades Repro-Med Systems (NASDAQ:KRMD) from Overweight to Neutral and lowers the price target from $9 to $4.5

Alex Nowak of Craig-Hallum maintained a buy recommendation and lowered price target to $7/share.

Estimated net sales for the Q4 are projected to be under $4million dollars. (computer by subtracting 9 month net sales of $20.1 million from the estimated $24 million annual sales.)
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent KRMD News